This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Market Edge Highlights: UFO, FINX, FIVE and ISRG
by Zacks Equity Research
Zacks Market Edge Highlights: UFO, FINX, FIVE and ISRG
Where to Find Great Investment Ideas
by Tracey Ryniec
Looking for some new stock and ETF ideas? Tracey and Neena share their secret sources.
Varian's (VAR) Halcyon to Treat Patients at Japan's Hospital
by Zacks Equity Research
Varian's (VAR) Halcyon sees encouraging developments in recent times.
Top Analyst Reports for Celgene, Schlumberger & Becton, Dickinson
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Celgene (CELG), Schlumberger (SLB) and Becton, Dickinson (BDX).
3 Medical Product Stocks Set to Beat This Earnings Season
by Urmimala Biswas
The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.
Intuitive Surgical (ISRG) Q1 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) Q1 results outside the United States impress.
5 Spectacular Large Cap Earnings Charts
by Tracey Ryniec
Which large cap earnings reports should you be watching this week?
Here's Why You Should Invest in Robotics ETFs
by Neena Mishra
Robotics, AI and automation are transforming our lives. Here's what investors need to know.
Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) Systems and Services revenues are likely to boost Q1 results.
Intuitive Surgical (ISRG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Intuitive Surgical (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News For Mar 18, 2019
by Zacks Equity Research
Markets closed in the green on Friday as optimism around a U.S. - China trade deal boosted investor sentiment.
Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright
by Zacks Equity Research
Intuitive Surgical (ISRG) fortifies its foothold in the global robotic-surgery market.
Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical (ISRG) closed at $558.29 in the latest trading session, marking a -0.08% move from the prior day.
RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio
by Zacks Equity Research
RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.
Top Stock Reports for Visa, Honeywell & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Honeywell (HON) and Biogen (BIIB).
Intuitive Surgical (ISRG) Up 2.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical (ISRG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical (ISRG) closed at $549.87, marking a +0.04% move from the previous day.
Intuitive Surgical Gets FDA Nod for Ion Endoluminal System
by Zacks Equity Research
The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Here's Why You Should Hold Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical's (ISRG) solid exposure to robotics & medical mechatronics is commendable. Its robot-based da Vinci Surgical System for minimally-invasive surgery is an added positive.
Top Stock Reports for United Technologies, Lockheed Martin & NextEra Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), Lockheed Martin (LMT) and NextEra Energy (NEE).
Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Intuitive Surgical (ISRG) closed at $494.25 in the latest trading session, marking a -0.5% move from the prior day.
Accuray & China Isotope Collaborate to Sell Radiation Devices
by Zacks Equity Research
Management at Accuray (ARAY) sees bright prospects in China.
Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ISRG) Outperforming Other Medical Stocks This Year?
Stock Market News for Jan 25, 2019
by Zacks Equity Research
Wall Street ended mixed on Thursday after investors received strong earnings numbers amidst lingering concerns over trade negotiations.
Intuitive Surgical (ISRG) Earnings Miss, Revenues Beat in Q4
by Zacks Equity Research
Solid show by flagship da Vinci system drives Intuitive Surgical's (ISRG) Q4 results.